100 episodi

Author interviews that explore the latest clinical reviews.

JAMA Clinical Reviews JAMA Network

    • Medicina
    • 5.0 • 3 valutazioni

Author interviews that explore the latest clinical reviews.

    The Winter COVID-19 Surge in New York and Los Angeles

    The Winter COVID-19 Surge in New York and Los Angeles

    Mitchell Katz, MD, president and chief executive officer of New York City Health + Hospitals, and former Los Angeles County health agency director, discusses causes, similarities, and differences between the spike of COVID-19 cases, hospitalizations, and deaths in the 2 cities.
    Related Article:
    Modernize Medical Licensing, and Credentialing, Too—Lessons From the COVID-19 Pandemic

    • 10 min
    Glaucoma Diagnosis and Treatment

    Glaucoma Diagnosis and Treatment

    Glaucoma is the most common cause of irreversible blindness in the world. Joshua Stein, MD, MS, associate professor of ophthalmology at the University of Michigan, reviews the diagnosis and treatment of glaucoma.
    Related Article:
    Glaucoma in Adults—Screening, Diagnosis, and Management

    • 19 min
    Oral Antibiotics for Appendicitis

    Oral Antibiotics for Appendicitis

    A new trial reports that a third of emergency department patients presenting with appendicitis admitted for oral antibiotic treatment had outcomes no different from those admitted for intravenous antibiotic treatment. Paulina Salminen, MD, PhD, professor of surgery at the University of Turku in Finland, discusses the findings.
    Related Article(s):
    Effect of Oral Moxifloxacin vs Intravenous Ertapenem Plus Oral Levofloxacin for Treatment of Uncomplicated Acute Appendicitis

    • 13 min
    Understanding the New SARS-CoV-2 Mutation Found in England

    Understanding the New SARS-CoV-2 Mutation Found in England

    Gregory Armstrong, MD, director of the Advanced Molecular Detection Program for the CDC, explains what is currently known about the new mutations of SARS-CoV-2.
    Related Article(s):
    Genetic Variants of SARS-CoV-2—What Do They Mean?
    Next-Generation Sequencing of Infectious Pathogens
    Next Generation Sequencing of Infectious Pathogens in Public Health and Clinical Practice
    Understanding SARS-CoV-2 Genetic Variants

    • 13 min
    Next Generation Sequencing of Infectious Pathogens in Public Health and Clinical Practice (Repost)

    Next Generation Sequencing of Infectious Pathogens in Public Health and Clinical Practice (Repost)

    Next-generation sequencing is a catchall term for new, high-throughput technologies that allow rapid sequencing of a full genome. It can be used to sequence a patient’s DNA in diagnosing a genetic disorder or characterizing a cancer, but it can also be used to sequence the genome of a pathogenic bacteria, virus, fungi, or parasites. In this JAMA clinical review podcast, we talk with authors Marta Gwinn, MD, MPH, and Gregory L. Armstrong, MD, from the CDC, about how next-generation sequencing of infectious pathogens is being implemented in clinical practice and in public health surveillance for infectious disease.
    Related Article(s):
    Next-Generation Sequencing of Infectious Pathogens
    Podcast originally published 2/14/19.

    • 25 min
    COVID-19 Vaccine Safety–Anaphylaxis and Allergic Reactions

    COVID-19 Vaccine Safety–Anaphylaxis and Allergic Reactions

    Tom Shimabukuro, MD, MPH, MBA, and Sara Mbaeyi, MD, MPH, from the CDC discuss rare allergic complications in patients who received the first dose of the Pfizer-BioNTech vaccine between December 14-23, 2020.

    • 16 min

Recensioni dei clienti

5.0 su 5
3 valutazioni

3 valutazioni

Top podcast nella categoria Medicina

Gli ascoltatori si sono iscritti anche a

Altri contenuti di JAMA Network